You are here: Industry Insights > Acquisition

News List

Recipharm acquires Kemwell’s pharmaceutical businesses in India for $118.5m pharmaceutical-technology
February 22, 2017
Sweden's Recipharm has completed the previously announced acquisition of Kemwell’s pharmaceutical businesses in Bengaluru, India, in a deal valued at Skr1.05bn ($118.5m).
Takeda completes acquisition of ARIAD Pharmaceuticals biospectrumasia
February 22, 2017
This acquisition will significantly enhances Takeda’s global oncology portfolio
Amygdala acquires Gilead’s candidate for addiction treatment pharmafile.com
February 21, 2017
Amygdala Neurosciences has agreed an acquisition with Gilead’s GS-6637.
Baxalta buy drives huge leap in Shire’s Q4 sales pharmatimes
February 20, 2017
Shire has booked sales of $3.62 billion for the fourth quarter, marking a leap of 123 percent driven by its acquisition of Baxalta last year.
Agilent Technologies to acquire multiplicom N.V., a leading european diagnostics company with state- pharmaasia
February 20, 2017
Agilent fortifies its target-enrichment portfolio through its planned acquisition of leading european diagnostics company Multiplicom N.V.
Catalent completes Accucaps acquisition cphi-online
February 20, 2017
Expands softgel development and manufacturing capabilities and capacity.
Cytori Completes Acquisition of Azaya Therapeutics Assets, Initiates Nanomedicine Program firstwordpharma
February 16, 2017
Cytori Therapeutics, Inc. (NASDAQ:CYTX) today announced it has completed its acquisition of assets of privately held Azaya Therapeutics, Inc.
Allergan to acquire US medical technology company Zeltiq for $2.47bn pharmaceutical-technology
February 15, 2017
Ireland-based biopharmaceutical company Allergan has signed an agreement to acquire US-based medical technology company Zeltiq Aesthetics in a deal valued at $2.47bn.
Allergan to Acquire ZELTIQ for $2.47B americanpharmaceuticalreview
February 14, 2017
Allergan and ZELTIQ® Aesthetics, Inc have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary adjustments.
Quotient Clinical Acquires SeaView Research contractpharma
February 07, 2017
Expands operations into the U.S.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 40 41 Next page